Condition
Mesothelioma
Estimated Enrollment: 90
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Primary Purpose: Treatment
Study ID Numbers: TL139204
Study First Received: May 21, 2008
Last Updated: May 22, 2008
Estimated Primary Completion Date: null
Primary Outcome Measures:
To determine the objective response rate of milataxel when given orally to previously treated patients with malignant mesothelioma.|To evaluate time to progression, duration of tumor response and safety and tolerability of TL139 treatment.
Sponsors and Collaborators:
Taxolog Inc.
Website Link: https://ClinicalTrials.gov/show/NCT00685204
